List of largest pharmaceutical companies by revenue

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
  1. Numbered list item

The following is a list of the top independent pharmaceutical & biotechnology companies ranked by their revenue generated ($10 billion) in the respective financial year, it does not include biotechnology companies that are now owned by, or part of, larger pharmaceutical groups.

The change is the companies relative position in this list, compared to their relative position in the prior year; i.e., an increase would be moving closer to rank 1 and vice versa. Green cells indicate years where revenue increased compared to the previous year, red cells indicate those years where there has been a decrease.

Top pharmaceutical companies with revenue greater than $10 billion[edit]

Rank Chg Company 2018
USD billions
2017
USD billions
2016
USD billions
2015
USD billions
2014
USD billions
2013
USD billions
2012
USD billions
2011
USD billions
1 Steady United States Johnson & Johnson
NYSEJNJ
81.60[1] 76.50[2] 71.89[3] 70.10[4] 74.30[5] 71.31[6] 67.20[7] 65.00[8]
2 Steady Switzerland Roche
SIXROG
56.86[9] 57.37[10] 50.11[11] 47.70[12] 49.86[13] 48.53[14] 47.80[15] 45.21[16]
3 Steady United States Pfizer
NYSEPFE
53.60[17] 52.54[18] 52.82[19] 48.85[20] 49.61[21] 51.58[22] 58.99[23] 65.26[24]
4 Steady Switzerland Novartis
NYSENVS
51.90[25] 49.11[26] 48.52[27] 49.41[28] 58.00[29] 57.36[30] 56.67[31] 58.57[32]
5 Increase 1 Germany Bayer
FWBBAYN
45.06[33] 27.76[34] 25.27[35] 24.09[36] 25.47[37] 24.17[38] 24.30[39] 23.11[40]
6 Increase 1 United Kingdom GlaxoSmithKline
LSEGSK
43.14[41] 42.05[42] 34.79[43] 29.84[44] 37.96[45] 41.61[46] 39.93[47] 41.39[48]
7 Increase 1 United States Merck & Co.
NYSEMRK
42.30[49] 40.10[50] 39.80[51] 39.50[52] 42.24[53] 44.03[54] 47.27[55] 48.05[56]
8 Steady France Sanofi
NYSESNY
39.07[57] 42.91[58] 36.57[59] 36.73[60] 43.07[61] 42.08[62] 46.41[63] 44.34[64]
9 Steady United States AbbVie
NYSEABBV
32.75[65] 28.22[66] 25.56[67] 22.82[68] 19.96[69] 18.79[70]
10 Steady United States Abbott Laboratories
NASDAQABT
30.60[71] 27.39[72] 20.85[73] 20.41[74] 20.25[75] 21.85[76] 39.87[77] 38.85[78]
11 Steady United States Eli Lilly & Co
NYSELLY
24.56[79] 22.90[80] 21.22[81] 20.00[82] 19.62[83] 23.11[84] 22.60[85] 24.29[86]
12 Steady United States Amgen
NASDAQAMGN
23.70[87] 22.80[88] 22.99[89] 21.66[90] 20.06[91] 18.68[92] 17.30[93] 15.58[94]
13 Increase 4 United States Bristol-Myers Squibb
NASDAQBMY
22.56[95] 20.80[96] 19.43[97] 16.56[98] 15.88[99] 16.39[100] 17.62[101] 21.24[102]
14 Increase 1 United States Gilead Sciences
NASDAQGILD
22.13[103] 25.70[104] 30.39[105] 32.15[106] 24.47[107] 10.80[108] 9.70[109] 8.39[110]
15 Decrease 1 United Kingdom AstraZeneca
LSEAZN
22.09[111] 22.47[112] 23.00[113] 24.71[114] 26.10[115] 25.71[116] 27.97[117] 33.59[118]
16 Steady Israel Teva Pharmaceutical Industries
NASDAQTEVA
18.90[119] 22.40[120] 21.90[121] 20.00[122] 20.27[123] 20.31[124] 18.31[125] 16.12[126]
17 Steady Germany Boehringer Ingelheim
Private
21.67[127] 17.54[128] 16.41[128] 17.70[128] 18.68[128] 18.89[128] 18.34[128]
18 Steady Germany Merck Group
ETR: MRK
8.83(Q2)[129] 18.70[130] 16.62[131] 14.25[132] 15.29[133] 14.73[134] 14.36[135] 14.31[136]
19 Steady Denmark Novo Nordisk
NYSENVO
16.99[137] 18.77[138] 16.61[139] 16.06[140] 15.83[141] 14.88[142] 13.48[143] 11.56[144]
20 Steady Republic of Ireland Allergan plc
NYSEAGN
15.78[145] 15.94[146] 14.57[146] 15.07[146] 12.88[147] 8.68[148] 5.91[149] 4.58[150]
20 Steady Japan Takeda Pharmaceutical
TYO: 4502[N 1]
12.68 (Q3) [151] 16.70[152] 15.96 14.93 16.84 17.36 18.91 17.80
21 Steady United States Celgene
NASDAQCELG
15.28[153] 13.00 11.23 9.26 7.67 6.49 5.51 4.84
22 Steady United States Biogen
NASDAQBIIB
13.45[154] 12.30[155] 11.40[156] 10.80[157] 9.70[158] 6.90[159] 5.50[160] 5.00[161]

See also[edit]

Notes[edit]

  1. ^ Includes the consolidated results of Shire plc from Q4 2018

References[edit]

  1. ^ "Johnson & Johnson Reports 2018 Fourth-Quarter Results:". Content Lab - U.S.
  2. ^ "Johnson & Johnson Reports 2017 Fourth-Quarter Results: - Johnson & Johnson". www.jnj.com.
  3. ^ "Johnson & Johnson Reports 2016 Fourth-Quarter Results - Johnson & Johnson". www.jnj.com.
  4. ^ "Johnson & Johnson Reports 2015 Fourth-Quarter Results:".
  5. ^ "Johnson & Johnson Reports 2014 Fourth-Quarter and Full-Year Results - Johnson & Johnson". www.jnj.com.
  6. ^ "Johnson & Johnson Reports 2013 Fourth-Quarter and Full-Year Results - Johnson & Johnson". www.jnj.com.
  7. ^ "Johnson & Johnson Reports 2012 Fourth-Quarter and Full-Year Results:".
  8. ^ "Johnson & Johnson Reports 2011 Fourth-Quarter and Full-Year Results:".
  9. ^ https://www.roche.com/dam/jcr:af865dfd-50fb-458b-9cac-34097db9d3ec/en/ar18e.pdf
  10. ^ "Roche reports good results in 2017". www.roche.com.
  11. ^ https://www.roche.com/dam/jcr:ee2f197f-5487-4629-9e28-66b77c9cbbab/en/ar16e.pdf
  12. ^ https://www.roche.com/dam/jcr:9b36e11d-495c-42f5-b757-e80c4e88d793/en/gb15e.pdf
  13. ^ https://www.roche.com/dam/jcr:880b44a1-3fd6-4e66-bf10-f4af1e724d4d/en/gb14e.pdf
  14. ^ https://www.roche.com/dam/jcr:64fd6b2d-1a76-467f-badd-ab94b85b6d70/en/gb13e.pdf
  15. ^ https://www.roche.com/dam/jcr:3e048249-e3ce-4969-a77e-cc90d8f3fa73/en/gb12e.pdf
  16. ^ https://www.roche.com/dam/jcr:52174b39-feab-4210-82f6-9b8786a69ecf/en/gb11e.pdf
  17. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Quarterly/2018/q4/Q4-2018-PFE-Earnings-Release.pdf
  18. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Quarterly/2017/Q4_2017_PFE_Earnings_Release.pdf
  19. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2016/2016-financial-report.pdf
  20. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2015/2015_Pfizer_Financial_Report.pdf
  21. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2014/2014_Pfizer_Financial_Report.pdf
  22. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2013/FinancialReport2013.pdf
  23. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2012/financial2012.pdf
  24. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2011/financial2011.pdf
  25. ^ https://www.novartis.com/sites/www.novartis.com/files/q4-2018-media-release-en.pdf
  26. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2017-en.pdf
  27. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2016-en.pdf
  28. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2015-en.pdf
  29. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2014-en.pdf
  30. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2013-en.pdf
  31. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2012-en.pdf
  32. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2011-en.pdf
  33. ^ https://www.annualreport2018.bayer.com/at-a-glance/fiscal-year-2018.html?pk_campaign=startseite&pk_source=Kennzahlen-btn-1#/datasheet-bayer_ar_oekonomisch/vertbar/0/0,1,2,3,4/figures/0
  34. ^ http://www.annualreport2017.bayer.com/servicepages/downloads/files/bayer_ar17_entire.pdf
  35. ^ http://www.annualreport2016.bayer.com/servicepages/downloads/files/bayer_ar16_entire.pdf
  36. ^ http://www.annualreport2015.bayer.com/servicepages/downloads/files/entire_bayer_ar15.pdf
  37. ^ AG, Bayer. "Bayer – Global Home". www.bayer.com.
  38. ^ https://www.bayer.com/en/ar-2013.pdfx
  39. ^ https://www.bayer.com/en/ar-2012.pdfx
  40. ^ https://www.bayer.com/en/ar-2011.pdfx
  41. ^ https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-sales-earnings-and-cash-flow-growth-in-2018/
  42. ^ https://www.gsk.com/media/4629/fy-2017-results-announcement.pdf
  43. ^ https://www.gsk.com/media/3609/annual-report-2016.pdf
  44. ^ https://www.gsk.com/media/2718/gsk-annual-report-2016.pdf
  45. ^ https://www.gsk.com/media/2710/gsk-annual-report-2014-interactive.pdf
  46. ^ https://www.gsk.com/media/2701/annual-report-2013-interactive.pdf
  47. ^ https://www.gsk.com/media/2694/annual-report-2012.pdf
  48. ^ https://www.gsk.com/media/2696/annual-report-2011.pdf
  49. ^ "Merck Announces Fourth-Quarter and Full-Year 2018 Financial Results". BioSpace.
  50. ^ LaVito, Angelica (2 February 2018). "Merck posts mixed fourth-quarter results as Keytruda sales skyrocket".
  51. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2017/Q4/merck-q4-10k.pdf
  52. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2015/annual/MRK_2015_Form_10-K_FINAL_r879.pdf
  53. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2014/annual/2014-Form-10-K_FINAL_022715.pdf
  54. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2013/annual/MRK_2013_Form_10_K_FINAL_022714.pdf
  55. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2012/annual/MRK_form_10_k_2012.pdf
  56. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2011/annual/form-10-k-2011.pdf
  57. ^ https://www.sanofi.com/-/media/Project/One-Sanofi-Web/Websites/Global/Sanofi-COM/Home/en/investors/docs/press-releases/Q42018results.pdf?la=en&hash=CDCE30350F0C658C000A909535AD9AF636A93560
  58. ^ https://www.sanofi.com/media/Project/One-Sanofi-Web/sanofi-com/en/investors/docs/press-releases/Press_release_Q4_FY_2017.pdf
  59. ^ https://en.sanofi.com/Images/49288_20-F_2016.pdf
  60. ^ https://en.sanofi.com/Images/45889_Sanofi_20-F_2015_V2.pdf
  61. ^ https://en.sanofi.com/Images/38473_Sanofi_20-F_2014.pdf
  62. ^ https://en.sanofi.com/Images/35795_20F_SANOFI_2013.pdf
  63. ^ https://en.sanofi.com/Images/31972_20-F_2012_V2.pdf
  64. ^ https://en.sanofi.com/Images/29804_20F_2011.pdf
  65. ^ "AbbVie Reports Full-Year and Fourth-Quarter 2018 Financial Results - AbbVie News Center". news.abbvie.com.
  66. ^ "Financial Release - AbbVie". investors.abbvie.com.
  67. ^ "Financial Release - AbbVie". investors.abbvie.com.
  68. ^ "Financial Release - AbbVie". investors.abbvie.com.
  69. ^ "Financial Release - AbbVie". investors.abbvie.com.
  70. ^ "Financial Release - AbbVie". investors.abbvie.com.
  71. ^ "Abbott Reports 2018 Results and Issues Strong Forecast for 2019". BioSpace.
  72. ^ Abbott. "Abbott Reports Fourth-Quarter 2017 Results". www.prnewswire.com.
  73. ^ Abbott. "Abbott Reports Fourth-Quarter 2016 Results". www.prnewswire.com.
  74. ^ "Abbott Reports Fourth-Quarter 2015 Results".
  75. ^ "Abbott Reports Fourth-Quarter 2014 Results".
  76. ^ Abbott. "Abbott Reports Fourth-Quarter and Full-Year 2013 Results". www.prnewswire.com.
  77. ^ "Abbott Reports Fourth-Quarter and Full-Year 2012 Results".
  78. ^ "Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2011 Earnings - FiercePharma". www.fiercepharma.com.
  79. ^ "Lilly Reports Strong Fourth-Quarter and Full-Year 2018 Financial Results, Lowers 2019 EPS Guidance to Reflect the Pending Acquisition of Loxo Oncology". BioSpace.
  80. ^ http://files.shareholder.com/downloads/LLY/5951368162x0x970018/15B962F7-AF5A-4FFA-BE13-42206D3A0820/Q4_2017_PressRelease.pdf
  81. ^ "Lilly Reports Fourth-Quarter and Full-Year 2016 Results (NYSE:LLY)". investor.lilly.com.
  82. ^ http://files.shareholder.com/downloads/LLY/5951368162x0x871993/5BE670A3-2B82-4876-8471-CA6BC3BD49F8/Lilly_Q4_2015_Press_Release.pdf
  83. ^ http://files.shareholder.com/downloads/LLY/5951368162x0x806120/8637C572-31C4-402E-A179-5E107A5366B2/Q414_Lilly_Sales_and_Earnings_Press_Release.pdf
  84. ^ http://files.shareholder.com/downloads/LLY/5951368162x0x721860/2DB60538-94FE-4E96-98D2-DA72CC301EA0/Q413%20Lilly%20Sales%20and%20Earnings%20Press%20Release.pdf
  85. ^ http://files.shareholder.com/downloads/LLY/5951368162x0x631117/85679233-E13C-4FE7-9431-E97EFFDA6D5D/Q412%20Lilly%20Sales%20and%20Earnings%20Press%20Release.pdf
  86. ^ http://files.shareholder.com/downloads/LLY/5951368162x0x538046/24A15621-7850-45EC-8E20-30535C3D9FC9/Q411_Lilly_Sales_and_Earnings_Press_Release.pdf
  87. ^ "Amgen - Investors - Press Release". investors.amgen.com.
  88. ^ "Amgen Reports Fourth Quarter And Full Year 2017 Financial Results". www.amgen.com.
  89. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NjY1NTQ1fENoaWxkSUQ9MzczMzk1fFR5cGU9MQ==&t=1
  90. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NjI2OTYzfENoaWxkSUQ9MzI5ODc3fFR5cGU9MQ==&t=1
  91. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NTc0NTMzfENoaWxkSUQ9Mjc3NjczfFR5cGU9MQ==&t=1
  92. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NTM3Nzc3fENoaWxkSUQ9MjI2ODE2fFR5cGU9MQ==&t=1
  93. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NDk5NjQxfENoaWxkSUQ9NTM5NDU4fFR5cGU9MQ==&t=1
  94. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MTM0MzEzfENoaWxkSUQ9LTF8VHlwZT0z&t=1
  95. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results - BMS Newsroom". news.bms.com.
  96. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results". investors.bms.com.
  97. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2016 Financial Results - BMS Newsroom". news.bms.com.
  98. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2015 Financial Results - BMS Newsroom". news.bms.com.
  99. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2014 Financial Results - BMS Newsroom". news.bms.com.
  100. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2013 Financial Results - BMS Newsroom". news.bms.com.
  101. ^ https://s21.q4cdn.com/104148044/files/doc_financials/annual_reports/Bristol-Myers-Squibb-2012AR-lr.pdf
  102. ^ https://s21.q4cdn.com/104148044/files/doc_financials/annual_reports/BristolMyersSquibb-2011-AnnualReport.pdf
  103. ^ "Gilead Sciences Announces Fourth Quarter and Full Year 2018 Financial Results". BioSpace.
  104. ^ "Investor Overview". Gilead Sciences.
  105. ^ "Investor Overview". Gilead Sciences.
  106. ^ "Investor Overview". Gilead Sciences.
  107. ^ "Investor Overview". Gilead Sciences.
  108. ^ "Investor Overview". Gilead Sciences.
  109. ^ "Investor Overview". Gilead Sciences.
  110. ^ "Investor Overview". Gilead Sciences.
  111. ^ https://www.astrazeneca.com/content/dam/az/PDF/2018/full-year/Full-Year_2018_Results_announcement.pdf
  112. ^ https://www.astrazeneca.com/content/dam/az/PDF/2017/Full-Year/Full-Year%202017%20Results%20announcement%20.pdf
  113. ^ https://www.astrazeneca.com/content/dam/az/PDF/Full_year_and_q4_2016_results/Full_Year_and_Q4_2016_Results_announcement.pdf
  114. ^ "Full-Year and Q4 2015 Results". www.astrazeneca.com.
  115. ^ "AstraZeneca PLC fourth quarter and full year results 2014". www.astrazeneca.com.
  116. ^ "AstraZeneca PLC fourth quarter and full year results 2013 - AstraZeneca". www.astrazeneca.com.
  117. ^ "AstraZeneca PLC Fourth quarter and full year results 2012". www.astrazeneca.com.
  118. ^ "AstraZeneca PLC Fourth quarter and full year results 2011". www.astrazeneca.com.
  119. ^ https://s22.q4cdn.com/366566841/files/doc_financials/2018/q4/PR_Q4.2018_Final_Feb.13.2019.pdf
  120. ^ "Teva Reports 2017 Full Year and Fourth Quarter Financial Results".
  121. ^ http://www.tevapharm.com/news/teva_reports_full_year_and_fourth_quarter_2016_financial_results_02_17.aspx
  122. ^ http://www.tevapharm.com/news/teva_reports_full_year_2015_and_fourth_quarter_financial_results_02_16.aspx
  123. ^ "Teva Reports Fourth Quarter and Full Year 2014 Results". www.tevapharm.com.
  124. ^ http://www.tevapharm.com/news/teva_reports_fourth_quarter_and_full_year_2013_results_02_14.aspx
  125. ^ "Teva Reports Fourth Quarter and Full Year 2012 Results". tevapharm.com.
  126. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MTI2NDkwfENoaWxkSUQ9LTF8VHlwZT0z&t=1
  127. ^ "Boehringer Ingelheim 2017 Annual Report" (PDF). www.boehringer-ingelheim.com.
  128. ^ a b c d e f "Boehringer Ingelheim total revenue 2007-2017 - Statistic". Statista.
  129. ^ "404 page - EMD Group". www.emdgroup.com.
  130. ^ "404 page - EMD Group". www.emdgroup.com.
  131. ^ http://ar2016.merckgroup.com/sites/default/files/downloads/en/merck_annual_report_2016.pdf
  132. ^ http://ar2015.emdgroup.com/sites/default/files/downloads/emd/Merck_GB2015_EN.pdf
  133. ^ http://ar2014.merckgroup.com/sites/default/files/downloads/en/Merck_GB2014_EN.pdf
  134. ^ "404 page - EMD Group". www.emdgroup.com.
  135. ^ "404 page - EMD Group". www.emdgroup.com.
  136. ^ "404 page - EMD Group". www.emdgroup.com.
  137. ^ https://www.novonordisk.com/content/dam/Denmark/HQ/investors/irmaterial/quarterly_financial_reports/2019/20190201_Financial%20statement%20Q4%202018_UK.pdf
  138. ^ "News details". www.novonordisk.com.
  139. ^ https://www.novonordisk.com/content/dam/Denmark/HQ/investors/irmaterial/quarterly_financial_reports/2017/20170202_Financial%20statement_FY%202016_UK.pdf
  140. ^ Transcripts, SA (3 February 2016). "Novo Nordisk's (NVO) CEO Lars Rebien Sorensen on Q4 2015 Results - Earnings Call Transcript".
  141. ^ Transcripts, SA (30 January 2015). "Novo Nordisk's (NVO) CEO Lars Sorensen on Q4 2014 Results - Earnings Call Transcript".
  142. ^ Transcripts, SA (31 January 2014). "Novo Nordisk A/S Management Discusses Q4 2013 Results - Earnings Call Transcript".
  143. ^ Transcripts, SA (31 January 2013). "Novo Nordisk's CEO Discusses Q4 2012 Results - Earnings Call Transcript".
  144. ^ http://www.novonordisk.co.uk/content/dam/Denmark/HQ/Commons/documents/Novo-Nordisk-AR-2011-en.pdf
  145. ^ "Allergan Reports Fourth Quarter and Full-Year 2018 Financial Results". BioSpace.
  146. ^ a b c https://www.allergan.com/news/news/thomson-reuters/allergan-reports-solid-finish-to-2017
  147. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NTczMDc2fENoaWxkSUQ9Mjc1MzEzfFR5cGU9MQ==&t=1
  148. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NTM5MDk2fENoaWxkSUQ9MjI4NjI0fFR5cGU9MQ==&t=1
  149. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MTc3MTM2fENoaWxkSUQ9LTF8VHlwZT0z&t=1
  150. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NDYwMzczfENoaWxkSUQ9NDg4Mzk1fFR5cGU9MQ==&t=1
  151. ^ "Takeda Reports Third Quarter FY2018 Results". BioSpace.
  152. ^ "Takeda reports FY2017 full year results and issues FY2018 guidance". www.takeda.com.
  153. ^ "Celgene Reports Fourth Quarter and Full Year 2018 Operating and Financial Results". BioSpace.
  154. ^ http://investors.biogen.com/static-files/c0d4fbe2-d4f2-404b-be17-19e770386d6e
  155. ^ "Biogen's Spinraza: Great Launch, Rough Ride". 25 January 2018 – via www.bloomberg.com.
  156. ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/Biogen_Annual_Report_2016_on_Form_10K.pdf
  157. ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/Biogen_Annual_Report_2015_on_Form_10K.pdf
  158. ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/Biogen_2014_Annual_Report_Web.pdf
  159. ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/BiogenIdec_AR_2013.pdf
  160. ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/BiogenIdec_AR_2012.pdf
  161. ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/2011ar.pdf

External links[edit]